Mesoblast Ltd - ADR
NASDAQ:MESO 4:00:00 PM EDT
| Market Cap (Intraday) | 1.68B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 21.51 |
| 10-Day MA | $14.63 |
| 50-Day MA | $13.88 |
| 200-Day MA | $13.73 |
Mesoblast Ltd - ADR Stock, NASDAQ:MESO
55 Collins Street, Level 38, Melbourne, Victoria (VIC) 3000
Australia
Phone: +61.3.9639.6036
Number of Employees: 73
Description
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.